Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) EV-to-Revenue : 3.08 (As of May. 25, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hainan Huluwa Pharmaceutical Group Co's enterprise value is ¥5,561 Mil. Hainan Huluwa Pharmaceutical Group Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,808 Mil. Therefore, Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue for today is 3.08.

The historical rank and industry rank for Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue or its related term are showing as below:

SHSE:605199' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.3 Med: 5.04 Max: 14.19
Current: 3.08

During the past 8 years, the highest EV-to-Revenue of Hainan Huluwa Pharmaceutical Group Co was 14.19. The lowest was 2.30. And the median was 5.04.

SHSE:605199's EV-to-Revenue is ranked worse than
61.04% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs SHSE:605199: 3.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Hainan Huluwa Pharmaceutical Group Co's stock price is ¥11.31. Hainan Huluwa Pharmaceutical Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.65. Therefore, Hainan Huluwa Pharmaceutical Group Co's PS Ratio for today is 2.43.

Hainan Huluwa Pharmaceutical Group Co EV-to-Revenue Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co EV-to-Revenue Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

8.25

7.38

4.37

3.60

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															4.40	4.03	3.99	3.60	3.32

Competitive Comparison of Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue falls into.

Hainan Huluwa Pharmaceutical Group Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	5561.252	/	1808.326
	=	3.08

Hainan Huluwa Pharmaceutical Group Co's current Enterprise Value is ¥5,561 Mil.
Hainan Huluwa Pharmaceutical Group Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,808 Mil.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hainan Huluwa Pharmaceutical Group Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	11.31	/	4.645
	=	2.43

Hainan Huluwa Pharmaceutical Group Co's share price for today is ¥11.31.
Hainan Huluwa Pharmaceutical Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.65.

Hainan Huluwa Pharmaceutical Group Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines